LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 2 filers reported holding LOXO ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $65,000 | 0.0% | 481 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $65,000 | -21.7% | 481 | -1.4% | 0.00% | -40.0% |
Q3 2018 | $83,000 | -8.8% | 488 | -7.0% | 0.01% | -50.0% |
Q2 2018 | $91,000 | +24.7% | 525 | -16.5% | 0.01% | – |
Q1 2018 | $73,000 | +305.6% | 629 | +188.5% | 0.00% | -100.0% |
Q4 2017 | $18,000 | -78.0% | 218 | -22.1% | 0.00% | -83.3% |
Q3 2017 | $82,000 | +2.5% | 280 | -72.0% | 0.01% | -33.3% |
Q2 2017 | $80,000 | +1900.0% | 1,000 | +941.7% | 0.01% | – |
Q1 2017 | $4,000 | – | 96 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |